Mettler Toledo (MTD)

NYSE Health Care Life Sciences Tools & Services S&P 500
$1,722.15
+43.07 (+2.57%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+2.8%
1M+12.6%
3M+20.6%
6M+53.1%
YTD+23.5%
1Y+19.6%
3Y+77.6%
5Y+16.3%

Key statistics

Full financials →
Market cap$34.2B
P/E (TTM)37.4
EPS (TTM, diluted)$46.10
P/S8.16
P/B441.07
EV / EBITDA—
Revenue (TTM)$4.20B
Revenue growth+6.5%
Net margin22.2%
ROE1,202.8%
Debt / equity26.06
FCF yield2.5%
Dividend yield—
Payout ratio—
Beta (1Y)0.79
Volatility (1Y)32.0%
52-week range$1,023.05 – $1,767.99
Avg volume (50D)208.19K

Revenue & net income — last 8 quarters

Statements →

Chart pattern: Ascending Channel (daily)

Forming
MTD Ascending Channel chart

Trigger $1,800.23 (+4.5% away). Details →

Nov 5, 4:33 PM ET

Mettler-Toledo Reports Third Quarter 2026 Results and Raises Full-Year Guidance

Positive earnings 2.02

Mettler-Toledo International Inc. reported third quarter 2026 net sales of $1.094 billion, representing a 6% increase compared to the prior-year period. Diluted earnings per share rose to $12.29 from $10.57, while adjusted EPS grew 13% to $12.57, driven by improving market demand and solid execution. Management also raised its full-year 2026 adjusted EPS guidance range to $47.70 to $47.90.

  • Reported net sales for the third quarter of 2026 increased 6% to $1.094 billion.
  • Diluted earnings per share were $12.29, compared with $10.57 in the third quarter of 2025.
  • Adjusted diluted EPS increased 13% to $12.57 from $11.15 in the prior-year period.
  • Full-year 2026 adjusted EPS is forecast to be between $47.70 and $47.90.
Read the filing on SEC.gov ↗
Aug 3, 4:48 PM ET

Mettler-Toledo appoints Natalia Shuman to board, increasing size to ten directors

Neutral leadership Written later 5.027.01

Mettler-Toledo said its Board appointed Natalia Shuman as an independent director effective August 3, 2026, and increased the Board from nine to ten directors. The filing does not yet state which Board committees she will serve on, and it reports no financial results or guidance.

  • Natalia Shuman appointed director effective August 3, 2026; Board size increases from nine to ten
  • Board has deemed Ms. Shuman independent under NYSE listing standards
  • Ms. Shuman is President and CEO of MISTRAS Group since January 2025 and previously led Bureau Veritas North America from 2017 to 2021
  • Committee assignments have not yet been determined
Read the filing on SEC.gov ↗
Jul 30, 4:32 PM ET

Mettler-Toledo raises 2026 adjusted EPS forecast to $47.15-$47.50 after Q2 profit rise

Positive earnings Written later 2.02

Mettler-Toledo reported second-quarter 2026 sales of $1.027 billion, up 4% from a year earlier, and diluted EPS of $11.55 versus $9.76. Adjusted EPS was $11.46, up 14%, and the company raised its full-year 2026 adjusted EPS forecast to $47.15-$47.50 from $46.30-$46.95. Results include a one-time net tariff refund benefit that management excludes from its non-GAAP figures.

  • Q2 2026 reported sales rose 4% to $1.027 billion; local currency sales rose 6% excluding a one-time tariff refund to customers.
  • Diluted EPS was $11.55 (up from $9.76); adjusted EPS was $11.46 (up 14% from $10.09).
  • Full-year 2026 adjusted EPS forecast raised to $47.15-$47.50 from $46.30-$46.95; Q3 adjusted EPS forecast is $12.00-$12.15.
  • Non-GAAP results exclude a one-time $52 million IEEPA tariff refund benefit to cost of sales and a related $28 million refund to customers that reduced net sales.
Read the filing on SEC.gov ↗
May 13, 8:56 AM ET

Mettler-Toledo grants 2026 executive equity awards; CEO target LTI value up about 6.25%

Neutral leadership Written later 5.02

On May 7, 2026, Mettler-Toledo's Compensation Committee approved 2026 long-term incentive awards for its named executive officers, split into equal May and November 2026 grants. The May grant, dated May 12, 2026, raised the CEO's target LTI value by about 6.25% versus 2025 and the other named executive officers' by about 12.5%, which shows how the company is compensating its leadership team.

  • Awards mix one-third performance share units, one-third non-qualified stock options and one-third restricted stock units, with half granted in May 2026 and half in November 2026.
  • May 2026 grant to CEO Patrick Kaltenbach: 838 PSUs, 2,005 stock options and 810 RSUs, based on the May 12, 2026 closing price.
  • RSUs carry a 3-year cliff vesting schedule; vesting for PSUs and options is unchanged.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own MTD

All investors →
InvestorValue% of portfolioLast quarter
Ray Dalio Bridgewater Associates $4.02M0.02% Reduced

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All MTD congressional trades →
TradedMemberTypeAmount
Dec 08, 2025Julia Letlow LA-05Sell$1,001 – $15,000
Jul 25, 2025Julia Letlow LA-05Buy$1,001 – $15,000
Dec 18, 2024Julia Letlow LA-05Buy$1,001 – $15,000
May 15, 2025Rob Bresnahan PA-08Buy$1,001 – $15,000
Apr 01, 2025Julie Johnson TX-32Sell$1,001 – $15,000
Apr 08, 2025Rob Bresnahan PA-08Sell$1,001 – $15,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Prices are end-of-day and split-adjusted. Financial data from Mettler Toledo's SEC XBRL filings. Not investment advice.